1. Home
  2. CNO vs TVTX Comparison

CNO vs TVTX Comparison

Compare CNO & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNO Financial Group Inc.

CNO

CNO Financial Group Inc.

HOLD

Current Price

$42.60

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$34.86

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNO
TVTX
Founded
1979
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Accident &Health Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.1B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
CNO
TVTX
Price
$42.60
$34.86
Analyst Decision
Hold
Strong Buy
Analyst Count
5
15
Target Price
$43.60
$37.21
AVG Volume (30 Days)
651.0K
1.4M
Earning Date
11-03-2025
10-30-2025
Dividend Yield
1.65%
N/A
EPS Growth
20.08
N/A
EPS
2.98
N/A
Revenue
$4,441,500,000.00
$435,826,000.00
Revenue This Year
N/A
$120.36
Revenue Next Year
$3.57
$37.33
P/E Ratio
$13.84
N/A
Revenue Growth
N/A
114.22
52 Week Low
$34.63
$12.91
52 Week High
$43.20
$37.50

Technical Indicators

Market Signals
Indicator
CNO
TVTX
Relative Strength Index (RSI) 67.54 54.48
Support Level $39.81 $33.84
Resistance Level $41.48 $35.97
Average True Range (ATR) 0.74 1.43
MACD 0.15 -0.33
Stochastic Oscillator 77.03 32.10

Price Performance

Historical Comparison
CNO
TVTX

About CNO CNO Financial Group Inc.

CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: